GlassScriptPhysician profile
Inderjeet Singh
NPI 1790766459
$18,780.49
in general payments reported to CMS, 2019-2025
9 companies · $7,898 in 2025
The $7,898 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $40.98 · 2024: $11K · 2025: $7,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Travel and Lodging: $3,508 · Food and Beverage: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,500.00 |
| Travel and Lodging | $3,507.96 |
| Food and Beverage | $1,772.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,079.37 | 2024-2025 | |
| Sanara Medtech INC. | $221.55 | 2024 | Celleraterx |
| Boston Scientific Corporation | $148.17 | 2024 | Spyglass Discover |
| Smith+Nephew, INC. | $110.13 | 2024-2025 | Renasys Touch, Pico, Renasys Go V2 Home |
| Phathom Pharmaceuticals, INC. | $102.59 | 2025 | Voquezna |
| Tela Bio, INC. | $59.03 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $23.41 | 2023 | Ligasure |
| Integra Lifesciences Corporation | $18.67 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $17.57 | 2023 | Echelon Flex, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inderjeet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.